Community pharmacists‘ attitudes towards clinical utility and ethical implications of pharmacogenetic testing

Author： Tuteja Sony Haynes Kevin Zayac Cara Sprague Jon E Bernhardt Barbara Pyeritz Reed

ISSN： 1741-0541

Source： Personalized Medicine, Vol.10, Iss.8, 2013-11, pp. : 793-800

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical implications of pharmacogenetic and microarray testing for advanced practice nurses

JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (ELECTRONIC), Vol. 27, Iss. 5, 2015-05 ,pp. : 246-255

John Wiley & Sons Inc

Access to resources Recommend Favorite

Meaningful Use and Clinical Utility of Preemptive Pharmacogenetic Testing: (Re)View From a CYP2D6 Poor Metabolizer

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 2, 2015-02 ,pp. : 119-121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical pharmacy consultation for pharmacogenetic testing

By Shin Jaekyu Kayser Steven R

Personalized Medicine, Vol. 6, Iss. 2, 2009-03 ,pp. : 183-192

Future Medicine

Access to resources Recommend Favorite

Attitudes of Health Care Professionals Toward Pharmacogenetic Testing

By Zgheib Nathalie K.

Molecular Diagnosis & Therapy, Vol. 15, Iss. 2, 2011-04 ,pp. : 115-122

Adis International

Access to resources Recommend Favorite

Clinical utility of DNA testing

By Tolias Peter Toruner Gokce A

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 461-464

Future Medicine

Access to resources Recommend Favorite